Changes in renal hemodynamics in streptozotocin-induced diabetic rats with L-ascorbic acid supplementation

Clinical Hemorheology and Microcirculation

Volumn 34, Issue 3, 2006, Pages 391-399

  Yusuksawad, Mariem S ^a   Chaiyabutr, Narongsak ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

L ascorbic acid; Renal hemodynamics; Streptozotocin induced diabetic rats

Indexed keywords

ASCORBIC ACID; BUFFER; CITRIC ACID; STREPTOZOCIN;

ANALYSIS OF VARIANCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD LEVEL; CALCULATION; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DIET SUPPLEMENTATION; GLOMERULUS FILTRATION RATE; HEART RATE; INULIN CLEARANCE; KIDNEY BLOOD FLOW; KIDNEY VASCULAR RESISTANCE; MALE; MATHEMATICAL ANALYSIS; MEAN ARTERIAL PRESSURE; NONHUMAN; RAT; RAT STRAIN; STREPTOZOCIN DIABETES; URINE FLOW RATE;

ANIMALS; ASCORBIC ACID; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; GLOMERULAR FILTRATION RATE; MALE; RATS; RATS, SPRAGUE-DAWLEY; RENAL PLASMA FLOW, EFFECTIVE; STREPTOZOCIN; VASCULAR RESISTANCE;

EID: 33645387973     PISSN: 13860291     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. S.M. Mauer, M.W. Steffes, E.N. Ellis, D.E.R. Sutherland and D.M. Brown, Structure-function relationships in diabetic nephropathy, J. Clin. Invest. 74 (1984), 1143-1155.
2. R. Osterby, Glomerular structural changes in type 1 (insulin-dependent) diabetes mellitus: causes, consequences, and prevention, Diabetologia 35 (1992), 803-812.
3. W. Zhang, P. Khanna, L.L. Chan, G. Campbell and N.H. Ansari, Diabetes-induced apoptosis in rat kidney, Biochem Mol. Med. 61 (1997), 58-62.
4. A.K. Salahuddeen, V. Kanji, J.F. Reckelhoff and A.M. Schmidt, Pathogenesis of diabetic nephropathy: a radical approach, Nephrol. Dial. Transplant 12 (1997), 664-668.
5. A. Heidland, K. Sebekova and R. Schinzel, Advanced glycation end products and the progressive course of renal disease, Am. J. Kidney Dis. 38(4 Suppl. 1) (2001), S100.
6. J.W. Baynes and S.R. Thorpe, Role of oxidative stress in diabetic complication: a new perspective on an old paradigm, Diabetes 48 (1999), 1-9.
7. P.S. Schein, D.A. Cooney, M.G. McMenamin and T. Anderson, Streptozotocin diabetes: further studies on the mechanism of depression of nicotinamide adenine dinucleotide concentrations in mouse pancreatic islets and liver, Biochem. Pharmacol. 22 (1973), 2625-2631.
8. C.K. Ho and S.A. Hashim, Pyridine nucleotide depletion in pancreatic islets associated with streptozotocin-induced diabetes, Diabetes 21 (1972), 789-793.
9. F. Lally and A.J. Bone, Animal models of type 1 diabetes, in: Textbook of Diabetes, 3rd edn, J.C. Pickup and G. Williams, eds, (Publisher name, place), 2003, pp. 19.2-19.4.
10. H.E. Sauberlich, Pharmacology of vitamin C, Ann. Rev. Nutrition 14 (1994), 371-391.
11. G. Seghieri, L. Martinoli, M. Miceli, M. Ciuti, G. D'Alessandri, A. Gironi, L. Palmieri, R. Anichini, G. Bartolomei and F. Franconi, Renal excretion of ascorbic acid in insulin dependent diabetes mellitus, Int. J. Vitam. Nutr. Res. 64 (1994), 119-124.
12. R.M. Lindsay, N.S.D. Jamieson, S.A. Walker, C.C. McGuigan, W. Smith and J. Baird, Tissue ascorbic acid and polyol pathway metabolism in experimental diabetes, Diabetologia 41 (1998), 516-523.
13. P.A. Craven, F.R. DeRubertis, V.E. Kagan, M. Melhem and R.K. Studer, Effects of supplementation with vitamin C or E on albuminuria, glomerular TGF-beta, and glomerular size in diabetes, J. Am. Soc. Nephrol. 8 (1997), 1405-1414.
14. K. Kedziora-Kornatowska, S. Szram, T. Kornatowski, L. Szadujkis-Szadurski, J. Kedziora and G. Bartosz, Effect of vitamin E and vitamin C supplementation on antioxidative state and renal glomerular basement membrane thickness in diabetic kidney, Nephron Exp. Nephrol. 95 (2003), e134-143.
15. A. Jaripongsakul, S. Patumraj, S. Yamaguchi and H. Niimi, The effect of long-term supplementation of vitamin C on leukocyte adhesion to the cerebral endothelium in STZ-induced diabetic rats. Clin. Hemorheol. Microcirc. 27 (2002), 67-76.
16. N. Chaiyabutr, V. Sitprija, S. Kato and N. Sugino, Effect of converting enzyme inhibitor on renal function of rats following Russell's viper venom administration, ICMR Annual 5 (1983), 169-179.
17. T. Suanarunsawat, S. Klongpanichapak and N. Chaiyabutr, Role of nitric oxide in renal function in rats with short and prolonged periods of streptozotocin-induced diabetes, Diabetes Obes. Metab. 1 (1999), 339-346.
18. H.W. Smith, Principle of Renal Physiology, Oxford Univ. Press, UK, 1962, p. 212.
19. B.A. Stanton and B.M. Koeppen, The kidney, in: Physiology, 3rd edn, R.M. Berne and M.N. Levy, eds, Mosby-Year Book, Inc., USA, 1993, p. 737.
20. E. Granstam and S.O. Granstam, Involvement of nitric oxide in the regulation of regional hemodynamics in streptozotocin-diabetic rats, Physiol. Res. 52 (2003), 159-169.
21. A.C. Pflueger, T.S. Larson, S. Hagl and F.G. Knox, Role of nitric oxide in intrarenal hemodynamics in experimental diabetes mellitus in rats, Am. J. Physiol. 277 (1999), R725-733.
22. T.H. Hostetter, H.G. Rennke and B.M. Brenner, The case for intrarenal hypertension in the initiation and progression of diabetic and other glomerulopathies, Am. J. Med. 72 (1982), 375-380.
23. K. Kaizu, Q.Y. Ling, K. Uriu, M. Ikeda, O. Hashimoto, N. Komine and S. Eto, The characteristics of renal hemodynamics in diabetic spontaneously hypertensive rats in comparison with diabetic Wistar-Kyoto rats, J. Diabetes Complications 9 (1995), 224-226.
24. L. Ditzel and M. Schwartz, Abnormally increased glomerular filtration rate in short-term insulin-treated diabetic subjects, Diabetes 16 (1967), 264-267.
25. T.H. Hostetter, J.L. Troy and B.M. Brenner, Glomerular hemodynamics in experimental diabetes, Kidney Int. 19 (1981), 410-415.
26. J.S. Christiansen, J. Gammelgaard, M. Frandsen and H. Hparving, Increased kidney size, glomerular filtration rate and renal plasma flow in short-term insulin-dependent diabetics, Diabetologia 20 (1981), 451-456.
27. N. Futrakul, P. Tohsukhowong, S. Patumraj, P. Siriviriyakul, N. Tipprukmas and P. Futrakul, Treatments of hemodynamic maladjustment and oxidative stress prevent renal disease progression in chronically severe glomerulonephritides, Ren. Fail. 25 (2003), 839-844.
28. S. Taddei, A. Virdis, L. Ghiadoni and A. Salvetti, Endothelial dysfunction in hypertension: fact or fancy, J. Cardiovasc. Pharmacol. 32(Suppl. 3) (1998), S41-S47.
29. N.K. Hollenberg, N.D. Price, D.A. Fisher, M.C. Lansang, B. Perkins, M.S. Gordon, G.H. Williams and L.M. Laffel, Glomerular hemodynamics and the renin-angiotensin system in patients with type 1 diabetes mellitus. Kidney Int. 63 (2003), 172-178.
30. H.S. Lim, R.J. MacFadyen and G.Y. Lip, Diabetes mellitus, the renin-angiotensin-aldosterone system, and the heart, Arch. Intern. Med. 164 (2004), 1737-1748.
31. G.J. Tortora and S.R. Grabowski, Principles of Anatomy and Physiology, 8th edn, John Willey & Sons Inc., New York, USA, 2000, pp. 931-932.
32. A. Spira, M. Gowrishankar and M.L. Halperin, Factors contributing to the degree of polyuria in a patient with poorly controlled diabetes mellitus, Am. J. Kidney Dis. 30 (1997), 829-835.
33. M. Usberti, S. Federico, B. Cianciaruso, R. Costanzo, D. Russo and V.E. Andreucci, Relationship between serum albumin concentration and tubular reabsorption of glucose in renal disease, Kidney Int. 16 (1979), 546-551.